Le Lézard
Classified in: Health
Subject: SVY

2020 Small Molecule API Contract Manufacturer Quality Benchmarking, 5th Edition - Current Outsourcing Trends & Practices, Quantitative Analysis of CMO Service Quality


DUBLIN, March 6, 2020 /PRNewswire/ -- The "Small Molecule API Contract Manufacturer Quality Benchmarking (5th Edition)" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

Small Molecule API Contract Manufacturing Quality Benchmarking brings with it a wealth of knowledge and information created with two goals in mind, help biopharmaceutical companies make more informed CMO decisions, and help CMOs optimize operational and marketing strategies.

This report provides pharmaceutical companies and contract manufacturers a comprehensive analysis of current outsourcing trends and practices, in addition to a quantitative analysis of CMO service quality across a series of 22 performance attributes specific to outsourced drug substance manufacturing. In this Consumer Report-style analysis, the publisher presents data on 455 service encounters from 158 respondents who have been involved in outsourced small molecule API projects in the past 18 months.

What You Will Learn

Drug Developers

Contract Manufacturers

Major Topics

Key Topics Covered

1. Outsourcing Philosophies and Practices

2. CMO Selection Drivers

3. CMO Perceptions and Interactions

4. CMO Performance and Loyalty

5. Small Molecule API CMO Competitive Landscape

6. Study Data

7. Demographics

For more information about this report visit https://www.researchandmarkets.com/r/kbu00s

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets


These press releases may also interest you

16 oct 2021
Core One Labs Inc. , , (the "Company") a research and technology company focused in life sciences and on bringing psychedelic medicines to market through novel delivery systems and psychedelic assisted psychotherapy, congratulates Seattle's city...

16 oct 2021
Neurocrine Biosciences, Inc.  today announced that it will present key information from its movement disorder treatments for Parkinson's disease and tardive dyskinesia (TD) at the American Neurological Association (ANA) 2021 Virtual Annual Meeting...

16 oct 2021
HLNY's highest recognition, the "Award of Distinction" will be presented to Arthur Gianelli, FACHE, Chief Transformation Officer of Mount Sinai Health System and President of Mount Sinai Morningside. This award recognizes a healthcare executive who...

16 oct 2021
Regulated Information ? Inside Information ? UCB, a global biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has informed the Company that they were unable to complete review of the Biologics License...

16 oct 2021
Throughout the unprecedented COVID-19 pandemic response, the Government of Canada has been providing significant support to provinces and territories. The Minister of Public Safety and Emergency Preparedness, the Honourable Bill Blair, confirmed that...

16 oct 2021
Transplant Québec is thrilled about the joint commitment announced yesterday at the Forum Québec by the provincial government and the three opposition parties. The announcement comes on the eve of World Organ Donation Day and in the wake of the first...



News published on 6 march 2020 at 11:00 and distributed by: